COPD News

Music may help improve cognitive function among people undergoing chemotherapy, according to results of a preliminary study.

Frailty progression occurred at a faster rate among patients with COPD and preserved ratio impaired spirometry vs. those with normal spirometry, according to results published in CHEST.

Healio Pulmonology has compiled the top news on COPD posted in 2024.

BOSTON — Compared with 17,800 patients starting new inhaled COPD maintenance therapy in 2016, 32,558 patients started a new inhaled treatment in 2022, according to a presentation at the CHEST Annual Meeting.

PHILADELPHIA — The current biologics for patients with COPD include anti-IL-5 therapies, dupilumab, tezepelumab and anti-IL-33 therapies, according to a presentation at the 2024 GOLD COPD International Conference.

PHILADELPHIA — Telehealth can be divided into three forms, all of which require more data to capture the full picture of its use in COPD care, according to a presentation at the 2024 GOLD COPD International Conference.

The accuracy of an artificial neural network in identifying COPD and Global Initiative for Chronic Obstructive Lung Disease, or GOLD, stage was similar with use of single-phase CT or inspiratory-expiratory CT, according to study results.

Having GERD, diabetes or osteoporosis in addition to COPD heightened the likelihood for exacerbations, ED visits and hospitalizations, according to results published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.

The FDA has accepted to review a supplemental new drug application for mepolizumab, an anti-IL-5 biologic, for treating patients with COPD plus an eosinophilic phenotype, according to a GSK press release.